Search Results

12,888 Results for "marinomed biotechnologie gmbh".

Sort By

Press Releases

T-CURX GmbH Enters into Technology Access Agreement with Kytopen

February 14, 2025
·
5 min read
Press Releases

Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers

February 25, 2025
·
3 min read
Deals

Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO

Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.

June 13, 2024
·
3 min read
Press Releases

Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH

January 14, 2025
·
3 min read
Business

Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH

Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.

April 9, 2024
·
2 min read
Press Releases

Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH

November 25, 2024
·
4 min read
Press Releases

FGK Clinical Research GmbH Highlights 3.5 Years of Success with Flex Databases

October 10, 2024
·
1 min read
Drug Development

HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data

HD Immune GmbH announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.

January 23, 2024
·
2 min read
Press Releases

Dovetail Genomics and Goenomics GmbH Announce Strategic Partnership to Enhance Genome Annotation Services

August 21, 2024
·
4 min read
Business

UroGen Secures Exclusive License from medac GmbH to Develop a Next-Generation Novel Mitomycin-Based Formulation for Urothelial Cancers

UroGen Pharma Ltd. today announced a licensing agreement with medac GmbH to develop a next-generation novel mitomycin-based formulation for urothelial cancers.

January 17, 2024
·
6 min read